Last edition
News about "ER-100 glaucoma trial"
Life Biosciences Reports First Human Data for ER-100 Trial
Life Biosciences has announced first-in-human data from ongoing phase 1 trial evaluating ER-100 in optic neuropathies.
ER-100 Glaucoma Trial | 13/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members